TAIPEI (Bernama): Taiwan-based Medigen Vaccine Biologics Corp (MVC) announced Monday (Feb 17) that it has teamed up with the US National Institutes of Health (NIH) to develop a vaccine against Covid-19 (novel coronavirus), Central News Agency (CNA) reported.
According to MVC, it signed an agreement with the NIH Sunday (Feb 16) allowing it to obtain the candidate vaccine virus and related material developed by the US health institution for potential use in humans to jump-start candidate vaccine development for Covid-19 in Taiwan.
Already a subscriber? Log in
Save 30% OFF The Star Digital Access
Cancel anytime. Ad-free. Unlimited access with perks.
